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RESULTSBACKGROUND
• Medication-Assisted Therapy (MAT) for opioid addiction 
has increased in Vermont over the past 10 years, 
supported by a novel “Hub and Spoke” system that 
integrates specialty treatment centers (“Hubs”) with 
primary care offices (“Spokes”). 1
• Vermont has the highest per capita use of buprenorphine-
based MAT in the US.1
• Barriers to successful MAT include: transportation, 
stigma, waiting time, insurance coverage, and others.2
• Studies of patient perspectives of MAT have identified 
social barriers (interference of treatment with work, 
school, or life obligations); rigid program rules; concerns 
about withdrawal and relapse as common causes of 
premature discontinuation of treatment.3
• In contrast, patients have reported a high-level of 
satisfaction with primary care office-based MAT.4
METHODS
DISCUSSION
• Patients in MAT have complex medical, mental health, social, 
personal, and work lives, all of which need attention to maximize 
treatment success. 
• Patients reported confidence in the Hub and Spoke system and 
high levels of self-efficacy.
• Sobriety, family support and developing independence motivated 
patients to succeed in the program.
• In this sample, patients felt well-supported by family, friends and 
the treatment system, but feelings of stigma remain.
• Some interactions with health providers were perceived as 
disrespectful and dismissive of pain complaints. Understanding 
health care provider and patient perspectives in these situations 
has the potential to suggest solutions.
FUTURE DIRECTIONS
Patient Perspectives on Medication Assisted Therapy in Vermont
Ashley Adkins, Holly Bachilas, Florence DiBiase, Michael Marallo, John Paul Nsubuga, Lloyd Patashnick, Curran Uppaluri, 
Elizabeth Cote, Charles MacLean MD, Jan Carney MD MPH
The Robert Larner, MD College of Medicine at the University of Vermont, Burlington, VT
• Guided interviews of 44 patients enrolled in MAT for opioid 
addiction at the 2 hubs of the Chittenden Clinic in 
Burlington, VT were conducted in October 2016.
• Questionnaire items were developed based on previous 
literature and discussion with program leadership, staff and 
clinicians and community stakeholders.
• Responses were organized using thematic content analysis 
with consensus across seven interviewers and two 
analysts.
Access, housing and financial problems were important 
barriers to successful treatment
1. Access
• 11/44 (25%) reported access issues, most commonly transportation 
or time commitment
2. Housing
• 27/44 (61%) have permanent housing, of which 7/44 (16%) are in 
section 8 housing
• 15/44 (34%) are transitory or live with relatives
3. Employment
4. System
Having a highly functioning treatment system and good 
social supports were important enablers of success
• 31/44 (70%) felt they understood the MAT system, though 
navigating the system was difficult when initiating treatment
• 30/44 (68%) had no issues with clinician availability
• 10/44 (23%) reported some negative experiences
5. Social Support & Stigma
• 36/44 (82%) felt well-supported to prevent relapse
• 23/44 (52%) felt they were supported by healthcare 
professionals
• 16/44 (36%) did not feel supported by healthcare 
professionals, feeling disrespected at times (both at MAT 
centers and other settings such as the Emergency 
Department)
• 18/44 (41%) highlighted at least one source of stigma
6. Self-Efficacy
7. Success
• 26/44 (59%) defined success as staying sober
• 12/44 (27%) defined success with feeling a sense of 
independence
8. Motivators
• 12/44 (27%) identified family as a major motivator
• 12/44 (27%) reported that being healthy, free from numerous 
hospitalizations was a motivator to continue treatment
1Integrated Treatment Continuum for Substance Use Dependence. Vermont Agency for Human Services. 2012.
2Peterson 2010. Why don’t out-of-treatment individuals enter methadone treatment programmes? Int J Drug 
Policy. Jan;21(1):36-42.
3Bentzley 2015. Patient Perspectives Associated with Intended Duration of Buprenorphine Maintenance Therapy. 
Journal of Substance Abuse Treatment. Vol. 56: 48-53
4Barry 2007. Patient Satisfaction with Primary Care Office-Based Buprenorphine/Naloxone Treatment. Journal of 
General Internal Medicine. 22(2):242-245.
Hub & Spoke graphic: http://www.healthvermont.gov/adap/documents/HUBSPOKEBriefingDocV122112.pdf
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• Develop a quantitative questionnaire for deployment 
across the statewide MAT system.
• Assess and understand common comorbid conditions 
and how they affect success in the program.
• Compare patient and provider perspectives to further 
inform system improvement and allocate resources 
effectively.
• Explore better ways to integrate social support services 
with substance abuse programs to create a unified 
system.
• Offer provider education on effective approaches to 
meet the needs of patients.
• Work to reduce stigma and increase empathy among 
both providers and communities. 
Table. Patient Characteristics N=44
Age, median (range) 34 (21-61)
Sex, % female 72%
Education
Less than high school diploma
High school diploma




Duration in treatment, median (range) 42 mo (2 wks - 25 yrs)
Multiple treatment attempts, % 52%





Dependent children, % 41%
“Sober Housing is crucial”
“It is easier to stay clean with good finances”
"Depends on the person. Sometimes they treat you like 
a dirt bag. Sometimes they respect you“
“My loved ones”
“Getting a good job and having a better life”
Comorbidities
• 22/44 (50%) of patients cited a comorbid mental health conditions, 
most commonly depression, anxiety, ADD/ADHD, PTSD
• 9/44 (20%) cited chronic pain 
• 5/44 (11%) cited a physical disability or musculoskeletal injury
Project goal
To elicit patient perspectives on barriers and 





















Confidence in the System and Self-Efficacy
10= Most Confident
Does this program give you the tools to succeed?
Do you feel you have the power to overcome your opioid addiction?
54%
18%
16%
7%
5%
Do Not Work
Work <30 hrs
Work >30 hrs
No Response
Volunteer
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